Goldman Sachs’s Ambev ABEV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEV
SCP
NAMI
BIP
ETC
Goldman Sachs's ABEV Position: Q2 2026 in Review
Goldman Sachs increased its Ambev (ABEV) stake by 79% in Q2 2026, buying an estimated $39.9M and bringing the position to 28,979,606 shares worth $91M. The position accounts for 0.01% of the portfolio, ranked #1288.
Goldman Sachs first reported a position in ABEV in Q4 2013 and has held it in 51 quarters since. The position peaked at $287M in Q3 2022. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.
- Goldman Sachs held 28,979,606 shares of Ambev worth $91M as of Q2 2026.
- Goldman Sachs bought 12,751,142 Ambev shares in Q2 2026, an estimated $39.9M.
- Ambev made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1288 holding.
- Goldman Sachs first reported a position in Ambev in Q4 2013 and has held it in 51 quarters since.
- Goldman Sachs's Ambev position peaked at $287M in Q3 2022.
- 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.